Global Next Generation Sequencing (NGS) Market Report: Assessment, Trends, and Forecast (2022-2027)
This new report provides an in-depth analysis of the global NGS market including assessment, trends, competition, and forecasts for 2022–2027. The report estimates the value of the global NGS market in 2022 at $10.9 billion. The NGS market is expected to grow at a 15% CAGR over the forecast period, reaching $21.7 billion in 2027.
Key growth drivers include increased utilization of NGS solutions and the development of new applications such as the use of liquid biopsy testing for early cancer detection and non-invasive prenatal testing. Oncology and reproductive health testing are the largest clinical specialties involved in NGS market growth. North America represents the largest regional NGS market. Among manufacturers, one company currently dominates the global marketplace, but numerous market entrants are making significant inroads in both research and clinical segments.
With a growing demand for the clinical application of NGS testing, market access and reimbursement remain the greatest barriers to widespread adoption.